EDITORIALS

Maintenance Therapy in Advanced Ovarian Cancer: Progression-Free Survival and Clinical Benefit

Robert F. Ozols

JCO Jul 1 2003: 2451–2453. [Full Text] [PDF]

Maybe More Is Better

Tate Thigpen

JCO Jul 1 2003: 2454–2456. [Full Text] [PDF]

Increasing Chemotherapy Intensity in Aggressive Lymphomas: A Renewal?

Bertrand Coiffier

JCO Jul 1 2003: 2457–2459. [Full Text] [PDF]

ORIGINAL REPORTS
Gynecologic Cancer
	Phase III Randomized Trial of 12 Versus 3 Months of Maintenance Paclitaxel in Patients With Advanced Ovarian Cancer After Complete Response to Platinum and Paclitaxel-Based Chemotherapy: A Southwest Oncology Group and Gynecologic Oncology Group Trial
	Maurie Markman, P.Y. Liu, Sharon Wilczynski, Bradley Monk, Larry J. Copeland, Ronald D. Alvarez, Caroline Jiang, and David Alberts
	JCO Jul 1 2003: 2460–2465. [Abstract] [Full Text] [PDF]

Hematologic Malignancies
	Dose-Intense Chemotherapy Every 2 Weeks With Dose-Intense Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone May Improve Survival in Intermediate- and High-Grade Lymphoma: A Phase II Study of the Southwest Oncology Group (SWOG 9349)
	Douglas W. Blayney, Michael L. LeBlanc, Thomas Grogan, Ellen R. Gaynor, Robert A. Chapman, C. Harris Spiridonidis, Sarah A. Taylor, Scott I. Bearman, Thomas P. Miller, and Richard I. Fisher
	JCO Jul 1 2003: 2466–2473. [Abstract] [Full Text] [PDF]
	High Response Rates and Lasting Remissions After Low-Dose Involved Field Radiotherapy in Indolent Lymphomas
	R.L.M. Haas, Ph. Poortmans, D. de Jong, B.M.P. Aleman, L.G.H. Dewit, M. Verheij, A.A.M. Hart, M.H.J. van Oers, M. van der Hulst, J.W. Baars, and H. Bartelink
	JCO Jul 1 2003: 2474–2480. [Abstract] [Full Text] [PDF]

Pediatric Oncology
	Cytochrome P450 CYP3A4/5 Expression as a Biomarker of Outcome in Osteosarcoma
	Hassan R. Dhaini, Dafydd G. Thomas, Thomas J. Giordano, Timothy D. Johnson, J. Sybil Biermann, Kirsten Leu, Paul F. Hollenberg, and Laurence H. Baker
	JCO Jul 1 2003: 2481–2485. [Abstract] [Full Text] [PDF]
	Correlation of Early Metastatic Response by123I-Metaiodobenzylguanidine Scintigraphy With Overall Response and Event-Free Survival in Stage IV Neuroblastoma
	Katherine K. Matthay, Veronique Edeline, Jean Lumbroso, Marie Laure Tanguy, Bernard Asselain, Jean Michel Zucker, Dominique Valteau-Couanet, Olivier Hartmann, and Jean Michon
	JCO Jul 1 2003: 2486–2491. [Abstract] [Full Text] [PDF]

Breast Cancer
	Phase II Study of the Efficacy and Tolerability of Two Dosing Regimens of the Farnesyl Transferase Inhibitor, R115777, in Advanced Breast Cancer
	Stephen R.D. Johnston, Tamas Hickish, Paul Ellis, Stephen Houston, Lloyd Kelland, Mitch Dowsett, Janine Salter, Bart Michiels, Juan Jose Perez-Ruixo, Peter Palmer, and Angela Howes
	JCO Jul 1 2003: 2492–2499. [Abstract] [Full Text] [PDF]
	Diet and Breast Cancer: Evidence That Extremes in Diet Are Associated With Poor Survival
	Pamela J. Goodwin, Marguerite Ennis, Kathleen I. Pritchard, Jarley Koo, Maureen E. Trudeau, and Nicky Hood
	JCO Jul 1 2003: 2500–2507. [Abstract] [Full Text] [PDF]

Central Nervous System
	Phase I Trial of Adenovirus-Mediated p53 Gene Therapy for Recurrent Glioma: Biological and Clinical Results
	Frederick F. Lang, Janet M. Bruner, Gregory N. Fuller, Kenneth Aldape, Michael D. Prados, Susan Chang, Mitchel S. Berger, Michael W. McDermott, Sandeep M. Kunwar, Larry R. Junck, William Chandler, James A. Zwiebel, Richard S. Kaplan, and W.K. Alfred Yung
	JCO Jul 1 2003: 2508–2518. [Abstract] [Full Text] [PDF]
	Effects of Radiotherapy on Cognitive Function in Patients With Low-Grade Glioma Measured by the Folstein Mini-Mental State Examination
	Paul D. Brown, Jan C. Buckner, Judith R. O’Fallon, Nancy L. Iturria, Cerise A. Brown, Brian P. O’Neill, Bernd W. Scheithauer, Robert P. Dinapoli, Robert M. Arusell, Walter J. Curran, Ross Abrams, and Edward G. Shaw
	JCO Jul 1 2003: 2519–2524. [Abstract] [Full Text] [PDF]

Head and Neck Cancer
	Phase II Study of First-Line Chemotherapy With Temozolomide in Recurrent Oligodendroglial Tumors: The European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971
	M.J. van den Bent, M.J.B. Taphoorn, A.A. Brandes, J. Menten, R. Stupp, M. Frenay, O. Chinot, J.M. Kros, C.C.D. van der Rijt, Ch.J. Vecht, A. Allgeier, and T. Gorlia
	JCO Jul 1 2003: 2525–2528. [Abstract] [Full Text] [PDF]
	Survival and Neurologic Outcomes in a Randomized Trial of Motexafin Gadolinium and Whole-Brain Radiation Therapy in Brain Metastases
	Minesh P. Mehta, Patrick Rodrigus, C.H.J. Terhaard, Aroor Rao, John Suh, Wilson Roa, Luis Souhami, Andrea Bezjak, Mark Leibenhaut, Ritsuko Komaki, Christopher Schultz, Robert Timmerman, Walter Curran, Jennifer Smith, See-Chun Phan, Richard A. Miller, and Markus F. Renschler
	JCO Jul 1 2003: 2529–2536. [Abstract] [Full Text] [PDF]

Gastrointestinal Cancer
	Expression Level of Valosin-Containing Protein Is Strongly Associated With Progression and Prognosis of Gastric Carcinoma
	Shinji Yamamoto, Yasuhiko Tomita, Yoshihiko Hoshida, Shuji Takiguchi, Yoshiyuki Fujiwara, Takushi Yasuda, Masahiko Yano, Shoji Nakamori, Masato Sakon, Morito Monden, and Katsuyuki Aozasa
	JCO Jul 1 2003: 2537–2544. [Abstract] [Full Text] [PDF]

Treatment-Related Complications
	Randomized, Placebo-Controlled Trial of Combined Pentoxifylline and Tocopherol for Regression of Superficial Radiation-Induced Fibrosis
	Sylvie Delanian, Raphael Porcher, Saida Balla-Mekias, and Jean-Louis Lefaix
	JCO Jul 1 2003: 2545–2550. [Abstract] [Full Text] [PDF]

Melanoma
	Randomized Phase II Study of Temozolomide Given Every 8 Hours or Daily With Either Interferon Alfa-2b or Thalidomide in Metastatic Malignant Melanoma
	S. Danson, P. Lorigan, A. Arance, A. Clamp, M. Ranson, J. Hodgetts, L. Lomax, L. Ashcroft, N. Thatcher, and M.R. Middleton
	JCO Jul 1 2003: 2551–2557. [Abstract] [Full Text] [PDF]
	Molecular Tumor Markers in the Blood: Early Prediction of Disease Outcome in Melanoma Patients Treated With a Melanoma Vaccine
	Robert A. Wascher, Donald L. Morton, Christine Kuo, Robert M. Elashoff, He-Jing Wang, Mehri Gerami, and Dave S.B. Hoon
	JCO Jul 1 2003: 2558–2563. [Abstract] [Full Text] [PDF]

Genitourinary Cancer
	Phase I Trial of Concurrent Twice-Weekly Recombinant Human Interleukin-12 Plus Low-Dose IL-2 in Patients With Melanoma or Renal Cell Carcinoma
	Jared A. Gollob, Korina G. Veenstra, Robert A. Parker, James W. Mier, David F. McDermott, Daniel Clancy, Linda Tutin, Henry Koon, and Michael B. Atkins
	JCO Jul 1 2003: 2564–2573. [Abstract] [Full Text] [PDF]

Lung Cancer
	Interobserver and Intraobserver Variability in Measurement of Non–Small-Cell Carcinoma Lung Lesions: Implications for Assessment of Tumor Response
	Jeremy J. Erasmus, Gregory W. Gladish, Lyle Broemeling, Bradley S. Sabloff, Mylene T. Truong, Roy S. Herbst, and Reginald F. Munden
	JCO Jul 1 2003: 2574–2582. [Abstract] [Full Text] [PDF]

Sarcomas
	Prognostic Factors in Primary Breast Sarcomas: A Series of Patients With Long-Term Follow-Up
	L. Zelek, A. Llombart-Cussac, P. Terrier, X. Pivot, J.M. Guinebretiere, C. Le Pechoux, T. Tursz, F. Rochard, M. Spielmann, and A. Le Cesne
	JCO Jul 1 2003: 2583–2588. [Abstract] [Full Text] [PDF]

Phase I and Clinical Pharmacology
	Perceptions of Patients and Physicians Regarding Phase I Cancer Clinical Trials: Implications for Physician-Patient Communication
	Neal J. Meropol, Kevin P. Weinfurt, Caroline B. Burnett, Andrew Balshem, Al B. Benson, III, Liana Castel, Sandra Corbett, Michael Diefenbach, Darrell Gaskin, Yun Li, Sharon Manne, John Marshall, Julia H. Rowland, Elyse Slater, Daniel P. Sulmasy, David Van Echo, Shakira Washington, and Kevin A. Schulman
	JCO Jul 1 2003: 2589–2596. [Abstract] [Full Text] [PDF]

ASCO SPECIAL ARTICLES

American Society of Clinical Oncology Technology Assessment Working Group Update: Use of Aromatase Inhibitors in the Adjuvant Setting

Eric P. Winer, Clifford Hudis, Harold J. Burstein, John Bryant, Rowan T. Chlebowski, James N. Ingle, Stephen B. Edge, Eleftherios P. Mamounas, Richard Gelber, Julie Gralow, Lori J. Goldstein, Kathleen I. Pritchard, Susan Braun, Melody A. Cobleigh, Amy S. Langer, Judy Perotti, Trevor J. Powles, Timothy J. Whelan, and George P. Browman

JCO Jul 1 2003: 2597–2599. First published on May 5 2003; 10.1200/JCO.2003.04.596. [Full Text] [PDF]

SPECIAL ARTICLES
	International Expert Panel on the Use of Primary (Preoperative) Systemic Treatment of Operable Breast Cancer: Review and Recommendations
	Manfred Kaufmann, Gunter von Minckwitz, Roy Smith, Vicente Valero, Luca Gianni, Wolfgang Eiermann, Anthony Howell, Serban Dan Costa, Philippe Beuzeboc, Michael Untch, Jens-Uwe Blohmer, Hans-Peter Sinn, Rolf Sittek, Rainer Souchon, Augustinos H. Tulusan, Tanja Volm, and Hans-Jörg Senn
	JCO Jul 1 2003: 2600–2608. [Abstract] [Full Text] [PDF]
Detection and Measurement of Occult Disease for the Prognosis of Solid Tumors
Tracy G. Lugo, Stephan Braun, Richard J. Cote, Klaus Pantel, and Valerie Rusch
JCO Jul 1 2003: 2609–2615. [Full Text] [PDF]

ART OF ONCOLOGY

When Your Favorite Patient Relapses: Physician Grief and Well-Being in the Practice of Oncology

Tait Shanafelt, Alex Adjei, and Frank L. Meyskens

JCO Jul 1 2003: 2616–2619. [Full Text] [PDF]

DIAGNOSIS IN ONCOLOGY

Some Unusual Paraneoplastic Syndromes: CASE 1. METASTATIC SQUAMOUS CELL ESOPHAGEAL CANCER TO THE THUMB

David Aguiar Bujanda, Uriel Bohn Sarmiento, and Jose Aguiar Morales

JCO Jul 1 2003: 2620. [Full Text] [PDF]

Some Unusual Paraneoplastic Syndromes: CASE 2. DIGITAL ULCERATION AS A PARANEOPLASTIC SYNDROME IN OVARIAN CANCER

Wendela G. Pronk, Jan P. Baars, Paul Chr. de Jong, and Anneke M. Westermann

JCO Jul 1 2003: 2620-a–2622. [Full Text] [PDF]

Some Unusual Paraneoplastic Syndromes: CASE 3. METASTATIC PULMONARY CALCIFICATION CAUSING HYPOXEMIA IN MALE BREAST CANCER

Ravi S. Agrawal, Jaya R. Agrawal, Bharat L. Agrawal, Amaresh R. Nath, Asha R. Agrawal, J.C. Gaddipat, and Richard F. Garnett, Jr

JCO Jul 1 2003: 2622–2624. [Full Text] [PDF]

Some Unusual Paraneoplastic Syndromes: CASE 4. PARANEOPLASTIC NEPHROTIC SYNDROME IN A PATIENT WITH LUNG CANCER

Benjamin Ebert, Kitt Shaffer, and Helmut Rennke

JCO Jul 1 2003: 2624–2625. [Full Text] [PDF]

SPECIAL DEPARTMENTS

Correspondence

Fludarabine Versus Cyclophosphamide, Vincristine, and Prednisone in Recurrent Low-Grade Lymphomas

Carol Alliot

JCO Jul 1 2003: 2626. [Full Text] [PDF]

In reply:

Richard J. Klasa

JCO Jul 1 2003: 2626-a–2627. [Full Text] [PDF]

Severe Radiation-Induced Proctitis Treated With Botulinum Anatoxin Type A

C. De Micheli, P. Fornengo, A. Bosio, G. Epifani, and C. Pascale

JCO Jul 1 2003: 2627. [Full Text] [PDF]

Errata

Errata

JCO Jul 1 2003: 2628. [Full Text] [PDF]

Errata

JCO Jul 1 2003: 2628-a. [Full Text] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.